ABVC BioPharma, Inc. Interest Income, Securities, US Treasury and Other US Government
ABVC BioPharma, Inc. (ABVC) reported Interest Income, Securities, US Treasury and Other US Government of $360.90 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment · last filed 2023-03-31
- ABVC BioPharma, Inc. interest income, securities, us treasury and other us government for the quarter ending 2021-12-31 was $104.17K.
- ABVC BioPharma, Inc. interest income, securities, us treasury and other us government for the quarter ending 2021-09-30 was $132.33K.
- ABVC BioPharma, Inc. interest income, securities, us treasury and other us government for fiscal 2021 was $360.90K.
| Period end | Interest Income, Securities, US Treasury and Other US Government 3 month | Interest Income, Securities, US Treasury and Other US Government 6 month | Interest Income, Securities, US Treasury and Other US Government 9 month | Interest Income, Securities, US Treasury and Other US Government 12 month |
|---|---|---|---|---|
| 2021-12-31 | $104.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $236.50K derived: sum of 2 quarters · filed 2023-03-31 | $360.90K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $132.33K 10-Q · filed 2022-11-14 | $256.73K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $124.40K 10-Q · filed 2022-08-15 |